06:30 min

SELEX-Based In Vitro Binding Assay to Identify RNA-Protein Interactions

07:16 min

Differential Scanning Calorimetry to Study DNA Aptamer-Thermolabile Ligand Interaction

04:29 min

Bimolecular Complementation Affinity Purification to Isolate Two Interacting Proteins

05:00 min

Fluorescence Anisotropy to Determine Transcription Factor-DNA Binding Affinity

07:05 min

Chromatin Immunoprecipitation to Identify Target Protein Binding Sites on Genomic DNA

06:34 min

Tandem Affinity Purification Assay to Study Protein-Protein Interactions

06:43 min

Graphene Biosensor-Based Field-Effect Biosensing to Detect Protein-Protein Interactions

03:52 min

Immunofluorescence Assay to Evaluate Effect of Target Proteins on Neurite Outgrowth

03:24 min

ATP-Based Luciferase Viability Assay: A Homogenous Method to Evaluate the Growth-Inhibitory Potential of Test Agents on Tumor Organoids

04:43 min

Topical Testing Assay: A Technique to Evaluate the Insecticidal Potential of Dopamine Receptor Antagonists on Adult Female Mosquitoes by Topical Application

04:46 min

Resorption Pit Assay: An In Vitro Technique to Quantify Calcium Resorption Activity of Mature Osteoclasts using Calcium Phosphate-Coated Culture Plates

07:37 min

Two-Dimensional Polyacrylamide Gel Electrophoresis: A Separation Technique for Analysis of Proteins in Complex Protein Mixture Based on Charge and Molecular Weight

Retroviral Mediated Gene Transduction: A Gene Transfer Technique to Deliver a Transgene in Cultured Cells Using Engineered Retroviral Vectors

作者：

简介：

Overview

This article describes the process of transducing host cells using RNA-containing retroviral vectors. It outlines the steps involved in ensuring efficient integration of transgenic RNA into the host genome.

Key Study Components

Area of Science

Neuroscience
Cell Biology
Gene Therapy

Background

Retroviral vectors are used to deliver genetic material into host cells.
The process involves the use of lipid bilayers to facilitate cell entry.
Understanding transduction efficiency is crucial for successful gene therapy applications.
Integration of transgenic RNA into the host genome is a key step in this process.

Purpose of Study

To demonstrate the methodology for transducing host cells with retroviral vectors.
To enhance understanding of the mechanisms involved in viral transduction.
To provide a protocol for researchers interested in gene delivery techniques.

Methods Used

Preparation of packaged retroviral vectors in suitable media.
Use of transfection reagents to promote viral adsorption onto target cells.
Centrifugation to increase transduction efficiency.
Collection and application of viral supernatant to host cells.

Main Results

Successful entry of viral capsid into host cells was achieved.
Transgenic RNA was effectively integrated into the host genome.
Protocol demonstrated reproducibility in transducing bone marrow cells.
Increased understanding of the role of viral enzymes in the transduction process.

Conclusions

The methodology outlined provides a reliable approach for gene delivery.
Understanding the transduction process is essential for advancing gene therapy.
Future studies can build on this protocol to explore further applications.

Frequently Asked Questions

What are retroviral vectors?

Retroviral vectors are tools used to deliver genetic material into cells, facilitating gene therapy.

How does transduction efficiency affect gene therapy?

Higher transduction efficiency increases the likelihood of successful gene integration and expression in target cells.

What role do viral enzymes play in transduction?

Viral enzymes are crucial for converting RNA into DNA and integrating it into the host genome.

Why is centrifugation used in this process?

Centrifugation helps bring the viral vectors closer to the host cell surface, enhancing transduction efficiency.

What precautions should be taken when handling viral vectors?

Proper biosafety measures should be followed to prevent contamination and ensure safe handling of viral materials.

To transduce host cells with RNA containing retroviral vectors, take a tube containing packaged vectors in suitable media. Each vector contains a viral capsid, containing the transgene's RNA complement to be integrated into the host genome and important viral enzymes. A lipid bilayer surrounds the capsid to facilitate entry into the host cell.

Add the vectors in the presence of a suitable transfection reagent to the well of a culture plate containing the host cell suspension. Cover the plate. Centrifuge at low speed to allow spin transduction. This brings the viral vector closer to the host cell surface, increasing transduction efficiency.

Simultaneously, the polycations in the transfection reagent neutralize negative charges on the virus and the host cell, promoting viral adsorption onto target cells.

Consequently, receptors on the virus surface facilitate its fusion with the host membrane. The viral capsid enters the cell and ruptures, releasing transgenic RNA and viral enzymes into its cytoplasm.

Inside the cytoplasm, the viral reverse transcriptase converts the RNA into a single-stranded complementary DNA, later changing it into double-stranded proviral DNA. The resultant DNA enters the nucleus. Viral integrase enzyme mediates the integration of proviral DNA into the host genome, resulting in transduced cells.

Collect fresh viral supernatant from the viral producer cell line. At this point, the cells should be well-spaced with a defined morphology. Next, carefully aspirate the top 2 milliliters of medium from each well of the 6-well plate containing the bone marrow cells. Avoid aspirating the bone marrow cells that are usually concentrated in the middle of the well.

Add 3 milliliters of freshly supplemented viral supernatant to each well of the 6-well plate containing bone marrow cells. After wrapping the plates in plastic, repeat the spin transduction, and then, place the unwrapped plates in the tissue culture incubator. After 24 hours on day three, remove and replace 2 milliliters of media from the wells.

标签: ,